What if an electronic medical record-based algorithm could make it easier and quicker to place individuals living with hepatitis C in the care cascade? That's exactly what one study is looking into, as it aims to help identify and get individuals wit...
One study set out to evaluate the role that the microbiome plays in HIV-associated neurocognitive disorders. Terri Wilder, M.S.W., spoke with study author Josue Perez-Santiago, Ph.D., at CROI 2017.
There is a significant "statin treatment gap" for people living with HIV, with only 47% of people eligible for statins receiving them in 2013, according to a recent study.
Incidence of all cancers combined fell in the years after HIV-positive people stopped smoking, according to results of a nine-year 35,424-person analysis.
Higher total bilirubin predicted incident cardiovascular disease in an analysis of 98,405 U.S. veterans with or without HIV infection.
The effect of even well-controlled HIV on the brain is not receiving enough attention. Now that people living with HIV no longer need to focus only on survival, quality-of-life issues must be addressed.
One subcutaneous dose of canakinumab, a monoclonal antibody to IL-1β, significantly reduced arterial inflammation in 10 individuals with well-controlled HIV.
Overweight or obese HIV-positive people randomized to an internet behavioral weight-loss program lost significantly more weight than those randomized to an internet educational program.
Among people starting their first antiretroviral therapy regimen, more advanced HIV disease and black race independently predicted severe weight gain through 96 weeks of follow-up.
Low body mass index and obesity, but not being overweight, predicted mortality and serious non-AIDS events, including cardiovascular disease and cancers, in a 41,149-person D:A:D study analysis.